In operation worldwide

Our innovative plants and technology are in operation worldwide.

These projects run at over 90% availability using an extremely wide range of feedstocks.

Project Overview

Turkey 1

PLANT: Organic waste plant – Organic waste recovery using Botres’ Bio-Scraper and anaerobic digestion plant with hygienisation and biogas treatment/desulphurisation

KEY FIGURES: Up to 1,300 m³ biogas/h; up to 3 MW electricity

PROJECT: Turnkey project; this is our second plant for this client, construction has started in march 2016. And is planned for completion at the end of 2016.


Turkey 2

PLANT: Biogas plant/industrial plant

KEY FIGURES: Up to 400 t/d cattle slurry, chicken waste and agricultural residue

1.4 MW electricity

PROJECT: Maximum prepareation for future expansion to a capacity of 2.8 MW electricity


South Korea

PLANT: Underground plant for a residue biorefinery with organic waste recovery and digestate processing

KEY FIGURES: 2.5 MW electricity; 75,000 t/y food waste and organic waste

PROJECT: Engineering and environmental impact assessment completed



PLANT: Residue biorefinery with waste recovery, biogas plant for heat and power, digestate treatment for fertiliser and composting

KEY FIGURES: 265,000 t/y organic waste for biogas, resulting in approx. 8 MW electricity (62,800 MWh/y); digestate treatment: 280 t/d

PROJECT: Largest organic waste recovery plant in Europe; success has resulted in investment in expansion

RESULTS: Approx. total 485,000 t/y organic waste processed (biogas and composting)



PLANT:  Residue biorefinery

KEY FIGURES: 2.5 MW electricity; approx. 75,000 t/y; 100% food waste

PROJECT: Client’s best performing plant; personel reference plant of the Botres Global Management Team



PLANT: Green biorefinery and demonstration plant; construction and operation: 2008-2012; development of Bio-A-Fraction for organic yeast

KEY FIGURES: Approx. 200 litre/h throughput

PROJECT: Own plant with Botres technology; investment and operation approx. EUR 3.5m

RESULTS: Successful testing of our patented technology; successful Bio-A-Fraction product development; subsequent FP7 project, Bisigodos, currently under way